PIRS (Pieris Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku
Pieris Pharmaceuticals (PIRS) develops Anticalin protein therapeutics to combat asthma and cancer. Outsourcing production and testing ensures structural flexibility, which is reflected in the relative EPS YoY trend, where this metric equals -70.20. Management is currently cutting secondary projects to preserve capital and seek partners in an effort to stabilize earnings per share dynamics.
Rincian metrik keuangan lan pasar Pieris Pharma (PIRS)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Koefisien Total Utang marang Modal Pieris Pharmaceuticals|PIRS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Pieris Pharmaceuticals Inc|PIRS - Utang perusahaan|Rasio utang marang aset resik Pieris Pharmaceuticals|PIRS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Pieris Pharmaceuticals|Koefisien jangkoan perantara pieris.com
- indikator pendapatan resik lan kelipatan nilai:
PIRS - Penghasilan resik|Penghasilan resik sing dikarepake Pieris Pharmaceuticals|PIRS - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Pieris Pharmaceuticals|PIRS - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Pieris Pharmaceuticals|PIRS - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Pieris Pharmaceuticals|PIRS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan pieris.com|PIRS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Pieris Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
Analisis dhasar perusahaan:Pieris (PIRS)
The development of innovative therapies by Pieris Pharmaceuticals (PIRS) is complicated by global geopolitical fragmentation, which disrupts component logistics and the execution of global clinical trials. The relative annual growth in net income per share quantifies the business's ability to generate earnings per share compared to the previous period, highlighting the effectiveness of cost management. The trend of this metric allows investors to assess the resilience of the business model to external shocks and the risk of falling into a value trap.
Pesaing langsung
Kacepetan wutah bathi saben saham ing taun lumaku Haleon Corp (HLN)|KVUE (Kenvue Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku veronapharma.com VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Dinamika bathi saben saham ing taun lumaku|ALVO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki liquidia.com LQDA|Galapagos (GLPG) - Wutah bathi saben saham ing taun lumaku|ANIP - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku MannKind Corporation|AMPH: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pacira BioSciences (PCRX)|SPRY: Dinamika bathi saben saham ing taun lumaku|Theravance Biopharma, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku AQST (Aquestive Therapeutics, Inc.)|SCPH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki tectonictx.com TECX|TNXP: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki SXTC|Wutah bathi resik saben saham ing taun iki EPRX|BioHarvest (BHST) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku EXOZ|Wutah bathi ing taun lumaku Oramed (ORMP)|Entera Bio Ltd. - Wutah bathi resik saben saham ing taun iki|ipatherapeutics.com (HYFT) - Kacepetan wutah bathi saben saham ing taun lumaku|ABVC - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku CPIX|QNTM: Wutah bathi ing taun lumaku|FGEN - Prakiraan wutah bathi resik saben saham ing taun iki|TELO (Telomir Pharmaceuticals Corp) - Wutah bathi ing taun lumaku|RANI (Rani Therapeutics) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku lexariabioscience.com LEXX|Wutah bathi ing taun lumaku Pulmatrix Corporation PULM|PTHL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Wutah bathi resik saben saham ing taun iki|IBO - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku TNF Pharmaceuticals, Inc.|Wutah bathi resik saben saham ing taun iki cbdMD, Inc. (YCBD)|Wutah bathi saben saham ing taun lumaku PainReform Limited (PRFX)|Wutah bathi resik saben saham ing taun iki Altamira Therapeutics Ltd CYTO|Wutah bathi ing taun lumaku LIPO (lipella.com)|Tambahing bathi saben saham ing taun lumaku OPTN|Procaps Group Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Wutah bathi saben saham ing taun lumaku|ACELYRIN (SLRN) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku TFF Pharmaceuticals
